IMA
ImageneBio, Inc.
6.25
+0.08+1.3%
Dec 16, 4:00:01 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
69.89M
P/E (TTM)
-
Basic EPS (TTM)
-4.77
Dividend Yield
0%

Recent Filings

About 

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

CEO
Ms. Erin Butler
IPO
3/26/2021
Website
https://www.inmagenebio.com
Sector
Healthcare
Industry
Biotechnology

Related Companies  

FBLG
FibroBiologics, Inc.
0.24-0.02
IMAB
I-MAB
4.63-0.01
IMMX
Immix Biopharma, Inc.
5.94-0.27
IMNM
Immunome, Inc.
23.48+0.84
IMRX
Immuneering Corporation
5.74-0.04
IMTX
Immatics N.V.
10.09+0.11
MAIA
MAIA Biotechnology, Inc.
1.23-0.12
TRML
Tourmaline Bio, Inc.
47.98+47.98
ZBIO
Zenas BioPharma, Inc.
36.89+4.30
ZURA
Zura Bio Limited
4.12+0.05